2,940 research outputs found
Double-blind trial of house-dust mite immunotherapy in asthmatic children resident at high altitude.
No full textTwenty-three Dermatophagoides pteronyssinus (Dpt)-sensitive asthmatic children
aged 7-14 years entered a double-blind, placebo-controlled trial of standardized
immunotherapy (IT) (Alpare) while resident at high altitude. Dpt sensitivity was
evaluated by skin prick tests at different allergen concentrations at the
enrollment and after 6 and 12 months of treatment. Bronchial hyperreactivity was
evaluated at the same time points, and on each occasion, histamine challenge and,
the following day, Dpt bronchial challenge were performed. All patients,
irrespective of active treatment, improved clinically and in lung function with
increased PC20 and Dpt-PD20. Alpare-treated patients had a significantly
decreased sensitivity on Dpt skin testing (P < 0.009) and felt that their asthma
had improved (P < 0.001) compared with placebo-treated subjects, but there was no
difference between the treatment groups in lung function or bronchial challenge
response. IT neither increased nor decreased bronchial histamine sensitivity. Our
results indicate that Dpt IT benefits asthmatic children, but improvement by
allergen avoidance at high altitude is even greater
Double-blind trial of house-dust mite immunotherapy in asthmatic children resident at high altitude
No full textTwenty-three Dermatophagoides pteronyssinus (Dpt)-sensitive asthmatic children aged 7-14 years entered a double-blind, placebo-controlled trial of standardized immunotherapy (IT) (Alpare) while resident at high altitude. Dpt sensitivity was evaluated by skin prick tests at different allergen concentrations at the enrollment and after 6 and 12 months of treatment. Bronchial hyperreactivity was evaluated at the same time points, and on each occasion, histamine challenge and, the following day, Dpt bronchial challenge were performed. All patients, irrespective of active treatment, improved clinically and in lung function with increased PC20 and Dpt-PD20. Alpare-treated patients had a significantly decreased sensitivity on Dpt skin testing (P < 0.009) and felt that their asthma had improved (P < 0.001) compared with placebo-treated subjects, but there was no difference between the treatment groups in lung function or bronchial challenge response. IT neither increased nor decreased bronchial histamine sensitivity. Our results indicate that Dpt IT benefits asthmatic children, but improvement by allergen avoidance at high altitude is even greater
Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma.
No full textBone metabolism and density have been shown to be abnormal in adult asthmatic patients treated with inhaled corticosteroids. Because the largest increases in bone growth and mineral deposition occur during childhood and adolescence, we performed a cross-sectional evaluation of cortical and trabecular bone mass by dual-photon absorptiometry at the proximal one third of the radius (cortical bone) and by dual-energy X-ray absorptiometry at the L2-L4 lumbar spine (trabecular bone) in 64 prepubertal asthmatic children receiving beclomethasone dipropionate (BDP) or cromolyn sodium (CS). Dual-energy X-ray absorptiometry was performed by anteroposterior scan and also by lateral vertebral scan in order to exclude the posterior elements of the vertebrae, which are composed mainly of cortical bone and which are less sensitive to the negative effect of steroids. Furthermore, we calculated "volumetric" bone density, dividing lateral mineral content by the vertebral volume. Bone mineral areal density and volume bone density did not differ in children receiving BDP for 6.7 +/- 1.3 mo at a mean dose of 319.3 +/- 130 micrograms/d compared with those in children treated with CS. Furthermore, anteroposterior bone density in our study population was in agreement with published normative data and with that of normal age-related healthy nonasthmatic children living in the same area and with the same dietary intake of calcium. No normal values are available for lateral and calculated-volume bone density. In conclusion, treatment with BDP does not appear to have an adverse effect on bone mass in prepubertal children with mild moderate asthma. Longitudinal studies should be performed in order to evaluate the effect of early introduction of inhaled corticosteroids in children with mild asthma
[Beta-2 agonists, exposure to allergens and bronchial hyperreactivity in children with allergic asthma]
No full textThe contribution of beta 2-agonist treatment per se and the effect of beta 2-agonists plus allergen exposure was evaluated in two groups of thirteen asthmatic children being treated respectively at sea level during the period of maximal allergen exposure and at high altitude in an environment free of the offending allergens. Bronchial hyperreactivity was evaluated by standardised exercise tests before and after treatment with salbutamol controlled release tablets (4 mg). Challenges were performed at the beginning and after 2 and 4 weeks of treatment. A fourth test was performed 2 days after stopping the treatment. Children treated with salbutamol at sea level (exposure to allergen) showed baseline delta PEF of 16.9 +/- 3.4 and 13.7 +/- 4.2, 20.7 +/- 4.3, 26.0 +/- 5.1 respectively for the second, third and fourth test. Children treated at high altitude showed respectively delta PEF of 34.9 +/- 5.1, 31.1 +/- 4.9, 26.5 +/- 5.4, 27.9 +/- 5.0. These data suggest that oral salbutamol per se is not responsible for an increase in bronchial responsiveness, but eventually suggest that treatment with beta 2-agonists at the same time as continued allergen exposure may be responsible for an increase in bronchial hyperresponsiveness
longitudinal evaluation of bone mass in asthmatic children treated with ihaled beclomethasone dipropionate of cromolyn sodium
No full textLC compensators for power factor correction of nonlinear loads
No full textThis material is posted here with permission of the IEEE. Such permission of the IEEE does not in any way imply IEEE endorsement of any of Brunel University's products or services. Internal or personal use of this material is permitted. However, permission to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution must be obtained from the IEEE by writing to [email protected]. Copyright @ 2004 IEEEA method is presented for finding the optimum fixed LC compensator for power factor correction of nonlinear loads where both source voltage and load current harmonics are present. The LC combination is selected because pure capacitive capacitors alone would not sufficiently correct the power factor. Optimization minimizes the transmission loss, maximizes the power factor, and maximizes the efficiency. The performance of the obtained compensator is discussed by means of numerical examples
Effect of beclomethasone dipropionate nasal aerosol on serum markers of bone metabolism in children with seasonal allergic rhinitis.
No full textThirty-nine children with grass pollen hay fever were randomly treated with nasal inhaled beclomethasone dipropionate (BDP) 200 or 400 microg/day or sodium cromoglycate (SCG) 30 mg/day for 2 months during the pollen season. Serum osteocalcin (OC), parathyroid hormone (PTH), total alkaline phosphatase (AP), bone alkaline phosphatase (BAP) and type I collagen telopeptide (ICTP) were measured immediately before, 1 and 2 months after treatment and 1 week after stopping the therapy. No significant changes in OC, PTH, AP, BAP and ICTP serum level occurred within each group. Minor and probably clinically insignificant between group differences were occasionally found. Our study shows that BDP nasal spray has no significant effect on common markers of bone metabolism
LC compensators based on transmission loss minimization for nonlinear loads
No full textThis material is posted here with permission of the IEEE. Such permission of the IEEE does not in any way imply IEEE endorsement of any of Brunel University's products or services. Internal or personal use of this material is permitted. However, permission to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution must be obtained from the IEEE by writing to [email protected]. Copyright @ 2004 IEEEThis paper presents a method employing the penalty function search algorithm to determine the LC compensator value for the optimal power factor correction in nonsinusoidal systems. The objective of the proposed method is to minimize the transmission loss while the power factor and efficiency are taken as constraints and utilized in order to solve the multiobjective optimization problem by transforming it into a single objective one. Examples show that the load nonlinearity can have a significant impact on optimal compensator sizes
Cost-effective applications of power factor correction for nonlinear loads
No full textThis material is posted here with permission of the IEEE. Such permission of the IEEE does not in any way imply IEEE endorsement of any of Brunel University's products or services. Internal or personal use of this material is permitted. However, permission to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution must be obtained from the IEEE by writing to [email protected]. Copyright @ 2005 IEEEThe objective of this paper is to propose a new approach for designing passive LC compensators by using the penalty function method as an optimization tool. The performance of the cost-effective passive LC compensator for a constant load depends on the appropriate inductor and capacitor selection. Several design methods are reviewed and a novel design methodology is proposed in this paper. By using the proposed method, the designer can quickly find appropriate parameter values to meet the desired circuit performance. Simulated results show that an appropriate combination of the inductor and capacitor selected by the proposed method can meet the desired power-quality requirement. Different cases of design examples are shown in this paper to verify the performance of the proposed design methodology
A 155W −95.6 dB THD+N GaN-based Class-D Audio Amplifier With LC Filter Nonlinearity Compensation
No full textSilicon MOSFETs-based medium-power (< 50W) Class-D amplifiers (CDAs) switching in the MHz range have gained popularity in recent years, which achieves better linearity thanks to a higher loop gain in the audio band while enabling the use of LC filters with higher cut-off frequencies. However, for high-power (>100 W) CDAs, such switching frequency and high load current could lead to significant power loss. Furthermore, in the presence of a large current and voltage applied to the load, the linearity of the system can quickly degrade due to LC filter component voltage/current dependency. Without any LC filter nonlinearity compensation technique, LC components with high voltage/current rating must be used to reach high system linearity, which are often expensive and bulky. This paper presents a CDA using a GaN-based output stage to achieve high switching frequency and good efficiency simultaneously, and an integrated controller implemented in a 180nm CMOS technology to compensate for the LC filter nonlinearity. Switching at 1.8 MHz, the CDA can deliver a maximum of 155W from a 50V supply into a load with a peak efficiency of 91.7%. It achieves a peak THD+N of −95.6 dB (0.0017%) while allowing the use of cheaper and smaller nonlinear LC components.Green Open Access added to TU Delft Institutional Repository 'You share, we take care!' - Taverne project https://www.openaccess.nl/en/you-share-we-take-care Otherwise as indicated in the copyright section: the publisher is the copyright holder of this work and the author uses the Dutch legislation to make this work public.Electronic Components, Technology and MaterialsMicroelectronic
- …
